prostate cancer
Conditions
Interventions
experimental group:Intraoperatively, after anesthesia, the collection device is arranged. As shown in the figure below, two double-stranded subcutaneous needles are inserted parallel into the cavernou
control group:The surgical procedure is the same as in the experimental group. During the surgery, the conventional method of visual identification by the surgeon's naked eye will be used to confirm t
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Males aged between 18 and 75 years; (2) Those with pathologically confirmed localized prostate cancer (clinical stage =T2cN0M0); (3) Defined as low risk according to the NCCN 2020 Prostate Cancer Guidelines (Gleason score =7); (4) International Index of Erectile Function-5 (IIEF-5) score of 18 or higher; (5) Normal erectile function before surgery; (6) Signed an informed consent form; (7) Those who have not undergone neoadjuvant endocrine therapy.
Exclusion criteria
Exclusion criteria: (1) Those with preoperative erectile dysfunction; (2) Those with a cardiac pacemaker or who have undergone other electrophysiological treatments; (3) Those with a history of abdominal or pelvic surgery or radiation therapy, or who have undergone transurethral resection of the prostate; (4) Those with central or peripheral nervous system disorders; (5) Those with severe underlying diseases, such as arrhythmias, heart failure, severe pulmonary insufficiency, etc.; (6) Those with severe anxiety, depression, mania, or psychiatric diseases, who are unable to cooperate with treatment and follow-up; (7) Those with a history of other malignant tumors; (8) Those with a severe allergic constitution; (9) Those whom the researcher considers unsuitable for participation for other reasons; (10) Those who require adjuvant endocrine therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IIEF-5 score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive Surgical Margin Rate (PSA Level).;Surgical Time;Intraoperative Blood Loss;Hospital Stay Duration;Perioperative Complications;Instrument Performance Evaluation; | — |
Countries
china
Contacts
Public ContactYao Lin
Peking University First Hospital
Outcome results
None listed